Glycine exerts dual roles in ischemic injury through distinct mechanisms

Stroke

Volumn 43, Issue 8, 2012, Pages 2212-2220

  Yao, Wen ^a,b   Ji, Fang ^a,b   Chen, Zheng ^a,b   Zhang, Nan ^a,b   Ren, Si Qiang ^a,b   Zhang, Xiao Yan ^a,b   Liu, Su Yi ^a,b   Lu, Wei ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Key Laboratory for Human Functional Genomics of Jiangsu Province   (China)

Author keywords

aspartate receptor; electrophysiology; glycine; ischemia; middle cerebral artery occlusion; N methyl D

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; GLUCOSE; GLYCINE RECEPTOR; GLYCINE TRANSPORTER 1; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; OXYGEN; SARCOSINE; STRYCHNINE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN SIZE; CONTROLLED STUDY; HIPPOCAMPAL CA1 REGION; IN VITRO STUDY; IN VIVO STUDY; LONG TERM POTENTIATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL EXCITABILITY; NERVE CELL LESION; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; STROKE; SYNAPTIC TRANSMISSION;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; BRAIN ISCHEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; GLYCINE; HIPPOCAMPUS; HYPOXIA, BRAIN; INFARCTION, MIDDLE CEREBRAL ARTERY; LONG-TERM POTENTIATION; MALE; PATCH-CLAMP TECHNIQUES; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOTAXIC TECHNIQUES; VIRUSES;

EID: 84864186968     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.645994     Document Type: Article

References (40)

1. Crepel V, Hammond C, Krnjevic K, Chinestra P, Ben-Ari Y. Anoxiainduced LTP of isolated NMDA receptor-mediated synaptic responses. J Neurophysiol. 1993;69:1774-1778.
2. Hsu KS, Huang CC. Characterization of the anoxia-induced long-term synaptic potentiation in area CA1 of the rat hippocampus. Br J Pharmacol. 1997;122:671-681.
3. Calabresi P, Centonze D, Pisani A, Cupini L, Bernardi G. Synaptic plasticity in the ischaemic brain. Lancet Neurol. 2003;2:622-629.
4. Oja SS, Saransaari P. Release of endogenous amino acids from the hippocampus and brain stem from developing and adult mice in ischemia. Neurochem Res. 2009;34:1668-1676.
5. Luccini E, Romei C, Di Prisco S, Raiteri M, Raiteri L. Ionic dysregulations typical of ischemia provoke release of glycine and GABA by multiple mechanisms. J Neurochem. 2010;114:1074-1084.
6. Xu TL, Gong N. Glycine and glycine receptor signaling in hippocampal neurons: diversity, function and regulation. Prog Neurobiol. 2010;91: 349-361.
7. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 1987;325:529-531.
8. Kemp JA, Leeson PD. The glycine site of the NMDA receptor-five years on. Trends Pharmacol Sci. 1993;14:20-25.
9. Danysz W, Parsons CG. Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev. 1998;50:597-664.
10. Keck T, White JA. Glycinergic inhibition in the hippocampus. Rev Neurosci. 2009;20:13-22.
11. Danglot L, Rostaing P, Triller A, Bessis A. Morphologically identified glycinergic synapses in the hippocampus. Mol Cell Neurosci. 2004;27: 394-403.
12. Perez-Otano I, Schulteis CT, Contractor A, Lipton SA, Trimmer JS, Sucher NJ, et al. Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J Neurosci. 2001;21: 1228-1237.
13. Sheng M, Cummings J, Roldan LA, Jan YN, Jan LY. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature. 1994;368:144-147.
14. Osten P, Khatri L, Perez JL, Kohr G, Giese G, Daly C, et al. Mutagenesis reveals a role for ABP/GRIP binding to GluR2 in synaptic surface accumulation of the AMPA receptor. Neuron. 2000;27:313-325.
15. Kim, M.J. et al. Differential roles of NR2A-and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron. 2005;46:745-760.
16. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 1994;12:529-540.
17. Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, et al. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci. 2007;27:2846-2857.
18. Chen M, Lu TJ, Chen XJ, Zhou Y, Qian Chen, Feng XY, et al. Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance. Stroke. 2008;39:3042-3048.
19. Lai TW, Shyu WC, Wang YT. Stroke intervention pathways: NMDA receptors and beyond. Trends Mol Med. 2011;17:266-275.
20. Katsuki H, Watanabe Y, Fujimoto S, Kume T, Akaike A. Contribution of endogenous glycine and d-serine to excitotoxic and ischemic cell death in rat cerebrocortical slice cultures. Life Sci. 2007;81:740-749.
21. Oda M, Kure S, Sugawara T, Yamaguchi S, Kojima K, Shinka T, et al. Direct correlation between ischemic injury and extracellular glycine concentration in mice with genetically altered activities of the glycine cleavage multienzyme system. Stroke. 2007;38:2157-2164.
22. Zhao P, Qian H, Xia Y. GABA and glycine are protective to mature but toxic to immature rat cortical neurons under hypoxia. Eur J Neurosci. 2005;22:289-300.
23. Tanabe M, Nitta A, Ono H. Neuroprotection via strychnine-sensitive glycine receptors during post-ischemic recovery of excitatory synaptic transmission in the hippocampus. J Pharmacol Sci. 2010;113:378-386.
24. Quintana P, Alberi S, Hakkoum D, Muller D. Glutamate receptor changes associated with transient anoxia/hypoglycaemia in hippocampal slice cultures. Eur J Neurosci. 2006;23:975-983.
25. Picconi B, Tortiglione A, Barone I, Centonze D, Gardoni F, Gubellini P, et al. NR2B subunit exerts a critical role in postischemic synaptic plasticity. Stroke. 2006;37:1895-1901.
26. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17:472-476.
27. Tortiglione A, Minale M, Pignataro G, Amoroso S, DiRenzo G, Annunziato L. The 2-oxopyrrolidinacetamide piracetam reduces infarct brain volume induced by permanent middle cerebral artery occlusion in male rats. Neuropharmacology. 2002;43:427-433.
28. Aarts M, Liu Y, Liu L, Besshoh S, Arundine M, Gurd JW, et al. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science. 2002;298:846-850.
29. Wang GH, Jiang ZL, Chen ZQ, Li X, Peng LL. Neuroprotective effect of L-serine against temporary cerebral ischemia in rats. J Neurosci Res. 2010;88:2035-2045.
30. Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin WP, et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther. 2004;2:302-317.
31. Rex CS, Gavin CF, Rubio MD, Kramar EA, Chen LY, Jia Y, et al. Myosin IIb regulates actin dynamics during synaptic plasticity and memory formation. Neuron. 2010;67:603-617.
32. Martina M, Gorfinkel Y, Halman S, Lowe JA, Periyalwar P, Schmidt CJ, et al. Glycine transporter type 1 blockade changes NMDA receptormediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. J Physiol. 2004;557:489-500.
33. Gotti B, Duverger D, Bertin J, Carter C, Dupont R, Frost J, et al. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. J Pharmacol Exp Ther. 1988;247:1211-1221.
34. Auberson YP, Allgeier H, Bischoff S, Lingenhoehl K, Moretti R, Schmutz M. 5-phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorg Med Chem Lett. 2002; 12:1099-1102.
35. Kalia LV, Kalia SK, Salter MW. NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol. 2008;7:742-755.
36. Nong Y, Huang YQ, Ju W, Kalia LV, Ahmadian G, Wang YT, et al. Glycine binding primes NMDA receptor internalization. Nature. 2003; 422:302-307.
37. Hardingham GE and Hilmar Bading. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci. 2010;11:682-696.
38. Stocca G, Vicini S. Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons. J Physiol. 1998; 507(Pt 1):13-24.
39. Tovar KR, Westbrook GL. Mobile NMDA receptors at hippocampal synapses. Neuron. 2002;34:255-264.
40. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem. 1984;43:1369-1374.